<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Structure and stability of artificial oxygen carriers by USAXS Experiment number: SC-5247</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Michael</forename><surname>Sztucki</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><forename type="middle">A</forename><surname>Schroer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Nanoparticle Process Technology (NPPT)</orgName>
								<orgName type="department" key="dep2">Faculty of Engineering</orgName>
								<orgName type="institution">University of Duisburg-Essen</orgName>
								<address>
									<addrLine>Lotharstr. 1</addrLine>
									<postCode>47058</postCode>
									<settlement>Duisburg</settlement>
									<country>Germany;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Katja</forename><forename type="middle">B</forename><surname>Ferenz</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Physiology</orgName>
								<orgName type="institution" key="instit1">University of Duisburg-Essen</orgName>
								<orgName type="institution" key="instit2">University Hospital Essen</orgName>
								<address>
									<addrLine>Hufelandstraße 55</addrLine>
									<postCode>45122</postCode>
									<settlement>Essen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">CeNIDE (Center for Nanointegration Duisburg-Essen)</orgName>
								<orgName type="institution">University of Duisburg-Essen</orgName>
								<address>
									<addrLine>Carl-Benz-Strasse 199</addrLine>
									<postCode>47057</postCode>
									<settlement>Duisburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Structure and stability of artificial oxygen carriers by USAXS Experiment number: SC-5247</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">0D4F3BB7CF0C26197AF71BE35EA8A73A</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T15:03+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>This experiment was performed remotely. Samples have been sent to ESRF, and data collection was performed by Michael Sztucki, while Martin Schroer was present via online conference system. Due to the cancellation of another beamtime, we received 9 shifts of beamtime.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>In this experiment, we determined the structure and stability of concentrated albumin-derived artificial oxygen carriers (A-AOC) in aqueous suspension, by combined ultra-small angle X-ray scattering (USAXS) and SAXS measurements. Utilizing the versatility of ESRF's ID02 beamline (variable sample-detector-distance of up to 31m; high photon flux), structural information from the micron to the nanometre range in aqueous environment have been accessible from medical relevant A-AOC suspensions over a broad concentration range.</p><p>In detail, data collection on aqueuous suspensions of A-AOCs was performed at several sample-detector distances (1 m; 8 m; 31 m), yielding in total an accessible q-range from 0.002 nm -1 to 7.5 nm -1 (covering a length scale range from 0.8 to 3000 nm). Scattering data were collected of A-AOCs from different synthesis approaches: Ultra-sound-assisted and microfluidizer-assisted <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref>. For each, sample concentrations from 20 to 0.2 wt% were studied at different temperatures (5°C to 65°C). Fig. <ref type="figure" target="#fig_0">1</ref> displays representative USAXS profiles for samples from two different synthesis approaches at selected temperatures. Specific differences of the A-AOCs are detectable: The structure and size of microfluidizer-based particles is stable for the whole temperature range covered, while gelation/aggregation between the particles is reflected from the increase at very small angles. In contrast, A-AOCs from the ultra-sound synthesis are not temperature-stable, but decrease in size.</p><p>Noteworthy, the contribution of unbound albumin is clearly visible from Fig. <ref type="figure" target="#fig_0">1b</ref>), indicating the sensitivity of the method for studying complex physiological sample systems over a wide length scale range.</p><p>Analysis of the USAXS profiles yields access to the particle size distribution (Fig. <ref type="figure" target="#fig_1">2</ref>). These data allow for the first time the correct size determination of the A-AOCs in aqueous solution, thus, in their medically relevant environment, as conventional characterization methods lack resolution or probe samples under non-physiological conditions.</p><p>As demonstrated, our USAXS measurements yielded access into both the ultrastructure and the stability of A-AOCs. Clearly, our different synthesis approaches lead to particle of different sizes and stability, as probed over a wide concentration and temperature range. Based on the (ongoing) data analysis, structure-stability correlations will be determined. These findings will promote the fine-tuning of our AOCsynthesis approaches.</p><p>We plan publish the experimental USAXS results within upcoming articles describing in detail the synthesis, structure, and stability of A-AOCs. The data will be also presented at the XVIII SAS2022 conference in Campinas and at Europhysiology 2022 in Copenhagen.  </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 :</head><label>1</label><figDesc>Figure 1: USAXS profiles, merged from measurements at different sampledetector distances. A-AOCs a) from microfluider (MOK)-and b) from ultrasound based synthesis, collected at different temperatures.</figDesc><graphic coords="2,207.36,36.48,374.40,193.44" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 :</head><label>2</label><figDesc>Figure 2: Size distribution determined for A-AOCs from two syntheses approaches: a) microfluidizer-assisted at different dilutions; b) ultrasoundassisted at different temperatures).</figDesc><graphic coords="2,223.20,293.04,368.88,142.32" type="bitmap" /></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Albumin-derived perfluorocarbon-based artificial oxygen carriers: A physico-chemical characterization and first in vivo evaluation of biocompatibility</title>
		<author>
			<persName><forename type="first">Anna</forename><surname>Wrobeln</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Julia</forename><surname>Laudien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christoph</forename><surname>Groß-Heitfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jürgen</forename><surname>Linders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christian</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Benjamin</forename><surname>Wilde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tanja</forename><surname>Knoll</surname></persName>
			<idno type="ORCID">0000-0001-8596-7592</idno>
		</author>
		<author>
			<persName><forename type="first">Dominik</forename><surname>Naglav</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Michael</forename><surname>Kirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Katja</forename><forename type="middle">B</forename><surname>Ferenz</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejpb.2017.02.015</idno>
	</analytic>
	<monogr>
		<title level="j">European Journal of Pharmaceutics and Biopharmaceutics</title>
		<title level="j" type="abbrev">European Journal of Pharmaceutics and Biopharmaceutics</title>
		<idno type="ISSN">0939-6411</idno>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="52" to="64" />
			<date type="published" when="2017-06">2017</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Wrobeln et al., Albumin-derived perfluorocarbon-based artificial oxygen carriers: A physico-chemical characterization and first in vivo evaluation of biocompatibility. Eur. J. Phar. Biopharm. 115, 52 (2017). (doi: 10.1016/j.ejpb.2017.02.015)</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Functionality of albumin-derived perfluorocarbon-based artificial oxygen carriers in the Langendorff-heart</title>
		<author>
			<persName><forename type="first">Anna</forename><surname>Wrobeln</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Klaus</forename><forename type="middle">D</forename><surname>Schlüter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jürgen</forename><surname>Linders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Manfred</forename><surname>Zähres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christian</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Michael</forename><surname>Kirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Katja</forename><forename type="middle">B</forename><surname>Ferenz</surname></persName>
		</author>
		<idno type="DOI">10.1080/21691401.2017.1284858</idno>
	</analytic>
	<monogr>
		<title level="j">Artificial Cells, Nanomedicine, and Biotechnology</title>
		<title level="j" type="abbrev">Artificial Cells, Nanomedicine, and Biotechnology</title>
		<idno type="ISSN">2169-1401</idno>
		<idno type="ISSNe">2169-141X</idno>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="723" to="730" />
			<date type="published" when="2017-02-08">2017</date>
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Wrobeln et al., Functionality of albumin-derived perfluorocarbon-based artificial oxygen carriers in the Langendorff-heart. Artific Cells Nanomed. Biotechnol. 45, 723 (2017). (doi: 10.1080/21691401.2017.1284858).</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Albumin-derived perfluorocarbon-based artificial oxygen carriers can avoid hypoxic tissue damage in massive hemodilution</title>
		<author>
			<persName><forename type="first">Anna</forename><surname>Wrobeln</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Johannes</forename><surname>Jägers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Theresa</forename><surname>Quinting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Timm</forename><surname>Schreiber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Michael</forename><surname>Kirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Joachim</forename><surname>Fandrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Katja</forename><forename type="middle">B</forename><surname>Ferenz</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41598-020-68701-z</idno>
	</analytic>
	<monogr>
		<title level="j">Scientific Reports</title>
		<title level="j" type="abbrev">Sci Rep</title>
		<idno type="ISSNe">2045-2322</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">11950</biblScope>
			<date type="published" when="2020-07-20">2020</date>
			<publisher>Springer Science and Business Media LLC</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Wrobeln et al., Albumin-derived perfluorocarbon-based artificial oxygen carriers can avoid hypoxic tissue damage in massive hemodilution. Sci. Rep. 10, 11950 (2020). (doi: 10.1038/s41598-020-68701-z).</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Artificial oxygen carriers in organ preservation: Dose dependency in a rat model of ex‐vivo normothermic kidney perfusion</title>
		<author>
			<persName><forename type="first">Johannes</forename><surname>Jägers</surname></persName>
			<idno type="ORCID">0000-0002-9815-2402</idno>
		</author>
		<author>
			<persName><forename type="first">Michael</forename><surname>Kirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Miriam</forename><surname>Cantore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ozan</forename><surname>Karaman</surname></persName>
			<idno type="ORCID">0000-0002-3293-9755</idno>
		</author>
		<author>
			<persName><forename type="first">Katja</forename><forename type="middle">Bettina</forename><surname>Ferenz</surname></persName>
			<idno type="ORCID">0000-0001-6011-2467</idno>
		</author>
		<idno type="DOI">10.1111/aor.14264</idno>
	</analytic>
	<monogr>
		<title level="j">Artificial Organs</title>
		<title level="j" type="abbrev">Artificial Organs</title>
		<idno type="ISSN">0160-564X</idno>
		<idno type="ISSNe">1525-1594</idno>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1783" to="1793" />
			<date type="published" when="2022-04-23">2022</date>
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">J. Jägers et al. Artificial oxygen carriers in organ preservation: Dose dependency in a rat model of ex-vivo normothermic kidney perfusion. Artif. Organs. 46, 1783 (2022). (doi: 10.1111/aor.14264).</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Deciphering the Emulsification Process to Create an Albumin-Perfluorocarbon-(o/w) Nanoemulsion with High Shelf Life and Bioresistivity</title>
		<author>
			<persName><forename type="first">J</forename><surname>Jägers</surname></persName>
		</author>
		<idno type="DOI">10.1021/acs.langmuir.1c03388</idno>
	</analytic>
	<monogr>
		<title level="j">Langmuir</title>
		<imprint>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note>in press</note>
	<note type="raw_reference">J. Jägers et al., Deciphering the Emulsification Process to Create an Albumin-Perfluorocarbon-(o/w) Nanoemulsion with High Shelf Life and Bioresistivity. Langmuir, in press (2022). (doi: 10.1021/acs.langmuir.1c03388).</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
